Table 3.
ChIP-seq design and results
| Sample | Strain | Genotype | Antibodya | Exptb | No. of reads | No. of mapped reads | % mapped |
|---|---|---|---|---|---|---|---|
| CenH3 | NMF241 | WTc | Anti-GFP | HTS41 | 22,648,972 | 1,868,888 | 8 |
| NMF166 | WT | Anti-GFP | HTS114d | 5,765,823 | 5,115,507 | 89 | |
| NMF233 | WT | Anti-GFP | HTS115d | 3,396,810 | 2,991,616 | 88 | |
| Total | 31,811,605 | 9,976,011 | 31 | ||||
| NMF239 | dim-5 | Anti-GFP | HTS61 | 941,134 | 831,702 | 88 | |
| NMF239 | dim-5 | Anti-GFP | HTS76 | 1,945,259 | 1,361,074 | 70 | |
| Total | 2,886,393 | 2,192,776 | 76 | ||||
| NMF232 | hpo | Anti-GFP | HTS42 | 23,465,182 | 2,824,712 | 12 | |
| CEN-C | NMF225 | WT | Anti-GFP | HTS125 | 16,749,444 | 14,853,136 | 89 |
| CEN-T | NMF399 | WT | Anti-GFP | HTS118d | 3,584,558 | 1,842,613 | 51 |
| H3K4me2 | NMF229 | WT | Anti-H3 K4me2 | HTS14 | 6,978,488 | 3,620,059 | 52 |
| H3K4me3 | NMF39 | WT | Anti-H3 K4me3 | HTS62 | 1,265,661 | 1,180,098 | 93 |
| NMF39 | WT | Anti-H3 K4me3 | HTS77 | 11,944,378 | 10,021,030 | 84 | |
| Total | 13,209,739 | 11,201,128 | 85 | ||||
| H3K9me3 | NMF39 | WT | Anti-H3 K9me3 | HTS111 | 14,638,703 | 12,672,192 | 87 |
| NMF166 | WT | Anti-H3 K9me3 | HTS120d | 4,818,433 | 4,229,931 | 88 | |
| MeDIP | NMF39 | WT | Anti-5meC | HTS18 | 4,588,332 | 1,713,181 | 37 |
Antibodies used: anti-GFP, Abcam ab290; anti-H3K4me2, Upstate 07-030; anti-H3K4me3, Active Motif AR-0169; anti-H3 K9me3, Active Motif 39161; anti-5me-C, Diagenode MAb-5MECYT-100.
Experiment names were used to submit data to the FFGED (see Materials and Methods).
WT, wild type.
Adapter sequence indicated for samples that were multiplexed: HTS114, ACGT; HTS115, CTGT; HTS118, CCCT; HTS120, GCTT.